DE69333351D1 - Rekombinante lipase aus hundemagen und pharmazeutische zusammensetzungen - Google Patents

Rekombinante lipase aus hundemagen und pharmazeutische zusammensetzungen

Info

Publication number
DE69333351D1
DE69333351D1 DE69333351T DE69333351T DE69333351D1 DE 69333351 D1 DE69333351 D1 DE 69333351D1 DE 69333351 T DE69333351 T DE 69333351T DE 69333351 T DE69333351 T DE 69333351T DE 69333351 D1 DE69333351 D1 DE 69333351D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
recombinant lipase
dog gum
recombinant
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69333351T
Other languages
English (en)
Other versions
DE69333351T2 (de
Inventor
Claire Blanchard
Claude Benicourt
Jean-Louis Junien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meristem Therapeutics SA
Original Assignee
Meristem Therapeutics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meristem Therapeutics SA filed Critical Meristem Therapeutics SA
Application granted granted Critical
Publication of DE69333351D1 publication Critical patent/DE69333351D1/de
Publication of DE69333351T2 publication Critical patent/DE69333351T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69333351T 1992-12-16 1993-12-16 Rekombinante lipase aus hundemagen und pharmazeutische zusammensetzungen Expired - Fee Related DE69333351T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9215201A FR2699179B1 (fr) 1992-12-16 1992-12-16 Acides nucléiques codant pour la lipase gastrique de chien et dérivés polypeptidiques, leur utilisation pour la production de ces polypeptides, et compositions pharmaceutiques à base de ces derniers.
PCT/FR1993/001260 WO1994013816A1 (fr) 1992-12-16 1993-12-16 Lipase gastrique du chien recombinante et compositions pharmaceutiques

Publications (2)

Publication Number Publication Date
DE69333351D1 true DE69333351D1 (de) 2004-01-22
DE69333351T2 DE69333351T2 (de) 2004-10-07

Family

ID=9436689

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69333351T Expired - Fee Related DE69333351T2 (de) 1992-12-16 1993-12-16 Rekombinante lipase aus hundemagen und pharmazeutische zusammensetzungen

Country Status (12)

Country Link
US (1) US5807726A (de)
EP (1) EP0674714B1 (de)
JP (1) JP4084411B2 (de)
AT (1) ATE256189T1 (de)
AU (1) AU703179B2 (de)
CA (1) CA2151381C (de)
DE (1) DE69333351T2 (de)
DK (1) DK0674714T3 (de)
ES (1) ES2213147T3 (de)
FR (1) FR2699179B1 (de)
PT (1) PT674714E (de)
WO (1) WO1994013816A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733249B1 (fr) * 1995-04-20 1997-06-06 Biocem Lipase gastrique de chien recombinante et polypeptides derives produits par les plantes, leurs procedes d'obtention et leurs utilisations
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
US6375947B1 (en) 1998-11-05 2002-04-23 International Flavors & Fragrances Inc. Recombinant kid pregastric esterase and methods for its production and use
US7033780B1 (en) * 1999-06-14 2006-04-25 Millennium Pharmaceuticals, Inc. Nucleic acids corresponding to TANGO 294 a gene encoding a lipase—like protein
US20030022279A1 (en) * 1999-06-14 2003-01-30 Fraser Christopher C. Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
EP1149585A1 (de) * 2000-04-27 2001-10-31 Warner-Lambert Company Verwendung einer rekombinanten Lipase aus Magen zur Behandlung der funktionellen Dyspepsia
FR2810667B1 (fr) * 2000-06-23 2004-09-03 Warner Lambert Co Procede d'isolement et de purification d'une proteine, et proteine obtenue
US6867030B2 (en) * 2001-03-29 2005-03-15 Applera Corporation Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof
GB201501081D0 (en) * 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8421210D0 (en) * 1984-08-21 1984-09-26 Celltech Ltd Polypeptide and polypeptide composition
FR2603804B1 (fr) * 1986-09-17 1989-10-27 Jouveinal Sa Lipases et extraits lipasiques, leur procede de preparation et leur application en therapeutique
DE3737333A1 (de) * 1987-11-04 1989-05-18 Basf Ag Verfahren zur herstellung eines biokatalysators und dessen verwendung zur razematspaltung

Also Published As

Publication number Publication date
ATE256189T1 (de) 2003-12-15
JPH08504580A (ja) 1996-05-21
CA2151381A1 (fr) 1994-06-23
AU5702994A (en) 1994-07-04
PT674714E (pt) 2004-04-30
JP4084411B2 (ja) 2008-04-30
US5807726A (en) 1998-09-15
WO1994013816A1 (fr) 1994-06-23
EP0674714A1 (de) 1995-10-04
AU703179B2 (en) 1999-03-18
ES2213147T3 (es) 2004-08-16
FR2699179A1 (fr) 1994-06-17
CA2151381C (fr) 2007-09-11
DE69333351T2 (de) 2004-10-07
EP0674714B1 (de) 2003-12-10
DK0674714T3 (da) 2004-04-13
FR2699179B1 (fr) 1995-01-06

Similar Documents

Publication Publication Date Title
DE69738581D1 (de) Menschliche dnase i hyperaktive varianten
PT1019040E (pt) Inibicao da actividade de p38-quinase por meio de arilureias
FR2712812B1 (fr) Composition pour la production de produits thérapeutiques in vivo.
TR200201094T2 (tr) Farmasötik maddeler olarak bisiklik amino asitler
IL162917A0 (en) A lysin from bacteriophage and pharmaceutical compositions containing the same
IL119989A0 (en) Pharmaceutical compositions for oral treatment of multiple sclerosis
HUP0001014A2 (hu) Gasztrointesztinális lipáz inhibitorok felhasználása
DE69333351T2 (de) Rekombinante lipase aus hundemagen und pharmazeutische zusammensetzungen
BG106008A (en) Novel lhrh antagonists with improved solubility characteristics
ATE285177T1 (de) Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen
DE69911401D1 (en) Immunoregulator
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
BG105275A (en) Tan-1057 derivatives
DE69638365D1 (de) Neue cytokinine aus vögeln und dafür codierende genetische sequenzen
BR9710448A (pt) Formula-{es farmac-uticas de sal de pot ssio sÄdioe tris oxaprozina
DE69935828D1 (de) Alkalische Ceramidase (E.C. 3.5.1.23) kodierendes Gen aus Pseudomonas aeruginosa
DE69529235T2 (de) Menschliche dnase i varianten
DE69730967D1 (en) Human dnase ii
ATE466025T1 (de) Physiologisch aktive peptide und medikamente, die diese enthalten
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
ES2191785T3 (es) Proteina de accion antitumoral.
MX9706429A (es) Variantes de dnasa i humana.
UA36167A (uk) Спосіб лікування панкреатиту

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee